S179
Brachytherapy - Urology
ESTRO 2026
Table 1. Kaplan-Meier Survival Curve. Conclusion:
Our results suggest that salvage brachytherapy is a safe and effective therapeutic option for certain patients with local recurrence of CaP after primary radiotherapy. Despite the absence of statistically significant predictive factors, the high biochemical control rate and acceptable toxicity support its use as a curative approach. Larger prospective studies are needed to better define patient selection criteria and optimise long-term oncological and functional outcomes. Keywords: prostate, recurrence, rescue References: López IH, Segundo CGS, Vegas JO, Gutierrez C, Hervas A, Rodriguez MÁC, et al. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy. Radiother Oncol. 1 de diciembre de 2019;141:156-63. Yamada Y, Kollmeier MA, Pei X, Kan CC, Cohen GN, Donat SM, et al. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy. 2014;13(2):111-6.
Made with FlippingBook - Share PDF online